Results 221 to 230 of about 379,741 (354)

Factors associated with the use of complementary therapies in Taiwanese patients with systemic lupus erythematosus: a cross-sectional study. [PDF]

BMC Complement Med Ther, 2021
Lu MC, Lo HC, Chang HH, Hsu CW, Koo M.
europepmc   +1 more source

Complementary and Alternative Medicine and Mind–Body Therapies for Treatment of Irritable Bowel Syndrome in Women [PDF]

, 2013
Suma Magge, Jacqueline L. Wolf
openalex   +1 more source

Interrogating the immune landscape of microsatellite stable RAS‐mutated colon cancer

Molecular Oncology, EarlyView.
COLOSSUS project RAS‐mutated MSS colon cancer study explored transcriptomics and immune cell density by immunohistochemistry (IHC), Immunoscore (IS), ISIC/TuLIS scores, mutation counts, and detected different prevalences but similar microenvironment composition across immune markers with clinical relevance for future immunotherapy combination ...
Rodrigo Dienstmann, Eduardo García‐Galea, Alice O'Farrell, Zak Kinsella, Maxime Meylan, Florent Petitprez, Ingrid Arijs, Tom Venken, Hari Ps, Adrian Lärkeryd, Ian Miller, Janick Selves, Nadja Meindl‐Beinker, Fiorella Ruiz‐Pace, Elena Élez, Raquel Comas‐Navarro, Frank Lincoln, Dirk Fey, Gift Nyamundanda, Aoife Nolan, Joern Lewin, Raquel Perez‐Lopez, Jonathan Briody, Kathleen Bennett, Walter Kolch, David Matallanas, Alexander Kel, Enrique Arenas, Joaquín Arribas, Bart Ghesquière, Josep Tabernero, Julie Meilleroux, Deborah McNamara, Ray McDermott, Marvin Lim, Mary O'Reilly, Brian Bird, Lisa Stack, Lucia Moloney, Patrick Morris, Keith Egan, Maciej Milewski, Lars Scheuer, Joachim Behringer, Georg Bolz, Ramon Salazar, Cristina Santos, Andrea Ruiz, Orla Casey, Verena Murphy, Matthias Ebert, Livio Trusolino, Diether Lambrechts, Anguraj Sadanandam, Catherine Sautès‐Fridman, Jochen Prehn, Paolo Nuciforo, Jacques Fieschi, Florence Monville, Darran O'Connor, Wolf Fridman, Annette Byrne   +61 more
wiley   +1 more source

Development of a core outcome set for the trials of complementary therapies in people with multiple sclerosis: international survey and consensus meetings. [PDF]

BMJ Open
Lopez-Alcalde J, Tietjen AK, Yan Y, Canella C, Barth J, Steinemann N, Hägele-Link S, Bolt S, Baum C, Rettenmund G, von Wyl V, Nonino F, Wieland LS, Wang X, Schmick A, Pagnini F, Kesselring J, Khazaei H, Pérez-Neri I, Studer-Merkle U, Witt CM.   +20 more
europepmc   +1 more source

Efficacy and Safety of Traditional Chinese Medicines as a Complementary Therapy Combined With Chemotherapy in the Treatment of Gastric Cancer: An Overview of Systematic Reviews and Meta-Analyses [PDF]

W J Xie, Yunsong Zhang, Jingyun Tang, Xiaolin Zhu, Shijun Wang, Meiqi Lu   +5 more
openalex   +1 more source

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

Molecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla, Christopher Dirks, Caroline Eiden, Sonja K. Fesenmayer, Femke M. Hormann, Yolande Klootsema, Ingrid Lilienthal, Si Min Zhang, Nikolas Herold, Sean G. Rudd   +9 more
wiley   +1 more source

Development and pilot testing of an empowerment-based educational app for complementary therapies in diabetes: a Delphi study. [PDF]

Int J Nurs Stud Adv
Chang HY, Huang YY.
europepmc   +1 more source

Revisiting Therapeutic Strategies for H. pylori Treatment in the Context of Antibiotic Resistance: Focus on Alternative and Complementary Therapies. [PDF]

Molecules, 2021
Cardos IA, Zaha DC, Sindhu RK, Cavalu S.
europepmc   +1 more source

Assessing Provider Knowledge and Attitude Towards Animal-Assisted Therapy as a Complementary Treatment for Children

, 2014
Shannon Leigh Million
openalex   +1 more source

Yoga as a complementary cancer therapy for mitigating oncological repercussions: A review

openalex   +1 more source